Acupuncture for ADHD: Acupoint Data Mining, Clinical Effectiveness, and Interviews to Explore Treatment Outcomes.

Launched by THE THIRD AFFILIATED HOSPITAL OF BEIJING UNIVERSITY OF CHINESE MEDICINE · Mar 5, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effects of acupuncture as a treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 to 12 years. The researchers want to see if acupuncture, either on its own or combined with traditional Chinese herbal treatments, can help improve symptoms of ADHD, such as difficulties with focus and behavior. The study will take place over 12 months, where children will be assessed through surveys and personal interviews to gather both statistical data and personal experiences related to their treatment.

To be eligible for the study, children must have a confirmed diagnosis of ADHD and an IQ score above 80. They should not have used any other medications or participated in other clinical trials within the last two weeks or three months, respectively. The trial aims to gather comprehensive information that could guide future ADHD treatments and improve the quality of care for children with this condition. If you decide to participate, you will undergo acupuncture sessions and share your experiences, helping us understand how effective this treatment can be for managing ADHD.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Patients will be considered for enrolment if they meet the criteria of:
• • A confirmed diagnosis of ADHD based on the DSM-5 criteria for ADHD (Western medical diagnosis) and in accordance with the ADHD Chinese Medicine Clinical Trial Design and Evaluation Technical Guidelines.
• • Aged between 6 and 12 years.
• • No use of any other pharmacological treatments (both Western and traditional Chinese medicine) within the two weeks prior to the start of the study.
• • An IQ score of greater than 80, as determined by the Raven's Progressive Matrices test.
• • The participant has not participated in any other clinical trials.
• Exclusion Criteria:
• Patients will be excluded from the study if they meet any of the following criteria:
• • Do not meet the inclusion criteria
• • Have comorbid psychiatric disorders, severe medical or psychiatric conditions that may interfere with the study (e.g., epilepsy, severe anxiety), pervasive developmental disorders, intellectual disability, or a history of suicidal or self-harming behavior
• • Have participated in any other drug clinical trials within the past 3 months.
• • Have severe comorbid conditions such as cardiovascular, hepatic, renal, or hematologic diseases.
• • Have any other conditions that the researchers believe may interfere with the assessment of treatment efficacy or safety.